Clarametyx Biosciences

Clarametyx Biosciences

Unleashing novel biologics to combat life-threatening infections by disrupting bacterial biofilms. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€120—180m (Dealroom.co estimates Jan 2024.)
Columbus Ohio (HQ)
Authorizing premium user...